Observational × Hematologic Neoplasms × Lymphoid × Clear all PERSIST
Enrolling by invitation
178 enrolled
LTFS
Enrolling by invitation
150 enrolled
TITLE CLL
Not yet recruiting
130 enrolled
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
Recruiting
135 enrolled
Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant
Recruiting
88 enrolled
Aquarius
Recruiting
550 enrolled
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Recruiting
30 enrolled
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Recruiting
99,999 enrolled
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Recruiting
2,000 enrolled
Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant
Active not recruiting
153 enrolled
Clinical Cohort of Lymphoma Patients in Malawi
Recruiting
800 enrolled
Besponsa Post Marketing Surveillance Study
Completed
108 enrolled 39 charts
Gene Therapy Follow-up Protocol for People Previously Enrolled in CAR-T Cell Studies
Enrolling by invitation
1,000 enrolled
Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies
Recruiting
100 enrolled
REBOUND
Completed
126 enrolled
Cardiovascular Reserve Evaluation in Survivors of Transplant, CREST Study
Active not recruiting
350 enrolled
Cardio CAR-T
Recruiting
60 enrolled
ABO and Rh Blood Group Frequencies in Acute Leukemia Patients
Not yet recruiting
300 enrolled
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
Recruiting
200 enrolled
SANGUINE
Recruiting
3,000 enrolled
Understanding What Matters Most to Patients: Establishing the Validity of a Best-Worst Scaling Survey
Completed
51 enrolled 8 charts
BELUGA
Recruiting
25,000 enrolled
HMvax-Regist
Withdrawn
DRP_ZH
Recruiting
1,000 enrolled
HemaTMA
Active not recruiting
5,000 enrolled
SARS-CoV-2 Donor-Recipient Immunity Transfer
Completed
26 enrolled
COVID19-hematological Malignancies: the Italian Hematology Alliance
Unknown
250 enrolled
I-PREDICT Heme
Terminated
13 enrolled
AutoCOVID-19
Completed
20 enrolled
THERMAL
Unknown
20 enrolled
HemoDiag
Recruiting
500 enrolled
SPIEVIE
Completed
40 enrolled
Rehabilitation Needs of the Malaysian Haematological Cancer Survivors
Completed
168 enrolled
Feasibility and Safety of Functional Performance Testing in Patients Undergoing Hematopoietic Cell Transplantation
Completed
11 enrolled
Relapsed Malignant Blood Cancer After Allogeneic Hematopoietic Stem Cell Transplantation
Terminated
56 enrolled 12 charts
PENELOPE Observational Study: Prophylaxis and Treatment of Arterial and Venous Thromboembolism
Completed
99 enrolled
A Study to Determine Final Geriatric Assessment in Haematology (GAH) Score as a Tool for Predicting Tolerance to Treatment in Elderly Patients (≥ 65 Years) With Haematologic Neoplasms
Completed
117 enrolled
Transplant-Related Mortality in Patients Undergoing a Peripheral Blood Stem Cell Transplantation or an Umbilical Cord Blood Transplantation
Completed
178 enrolled
Pilot Study of Reduced-Intensity Umbilical Cord Blood Transplantation in Adult Patients Wtih Advanced Hematopoietic Malignancies
Terminated
15 enrolled
Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia
Completed
44 enrolled
Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic Patients
Completed
801 enrolled
The Collection of Peripheral Blood Lymphocytes and Marrow Progenitor Cells From Normal Volunteers and Volunteers With Lymphoid or Hematologic Malignancies
Completed
75 enrolled